a public good project by the
Synthesis
Company
of California

© 2026

Bjarne Bogen | doi.page

0 works0 citations0 h-index

Bjarne Bogen

Oslo University Hospital(NO)Universidade do Porto(PT)University of Oslo(NO)

Publications by Year

Research Areas

Immunotherapy and Immune Responses, T-cell and B-cell Immunology, Immune Cell Function and Interaction, Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research

Most-Cited Works

→ Unsupervised High-Dimensional Analysis Aligns Dendritic Cells across Tissues and Species(2016)781 cited
→ Endocytic pathways regulate Toll‐like receptor 4 signaling and link innate and adaptive immunity(2006)482 cited
→ Primary Antitumor Immune Response Mediated by CD4+ T Cells(2005)468 cited
→ The Inhibitor of Death Receptor Signaling, Flice-Inhibitory Protein Defines a New Class of Tumor Progression Factors(1999)421 cited
→ Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer(2011)309 cited
→ MHC class II—Restricted presentation of intracellular antigen(1991)256 cited

→ B-lymphoma cells process and present their endogenous immunoglobulin to major histocompatibility complex-restricted T cells.(1989)

222 cited

→ Cutting Edge: Expression of XCR1 Defines Mouse Lymphoid-Tissue Resident and Migratory Dendritic Cells of the CD8α+ Type(2011)213 cited

→ Broad and Largely Concordant Molecular Changes Characterize Tolerogenic and Immunogenic Dendritic Cell Maturation in Thymus and Periphery(2016)211 cited

→ How Do CD4+ T Cells Detect and Eliminate Tumor Cells That Either Lack or Express MHC Class II Molecules?(2014)203 cited